Hematology
Blood & lymphatic clinical trials
Anemia, clotting disorders, and other conditions of the blood and lymphatic system. We’re tracking 5,086 recruiting studies in this area right now.
By phase
- Not applicable2,108
- Phase 21,118
- Phase 1823
- Phase 1/Phase 2484
- Phase 3349
- Phase 4126
- Phase 2/Phase 378
Top conditions
- Multiple Myeloma333
- Acute Myeloid Leukemia292
- Lymphoma182
- Sickle Cell Disease142
- Myelodysplastic Syndromes129
- Acute Lymphoblastic Leukemia123
- Chronic Lymphocytic Leukemia100
- Leukemia100
- Follicular Lymphoma74
- Hematologic Malignancy68
- Myelodysplastic Syndrome68
- Hodgkin Lymphoma67
- Mantle Cell Lymphoma62
- Anemia60
- Diffuse Large B Cell Lymphoma57
- Lymphedema49
- Non-Hodgkin Lymphoma49
- Small Lymphocytic Lymphoma49
Leading sponsors
- Institute of Hematology & Blood Diseases Hospital, China148
- M.D. Anderson Cancer Center147
- National Cancer Institute (NCI)96
- The First Affiliated Hospital of Soochow University68
- Memorial Sloan Kettering Cancer Center65
- Mayo Clinic61
- City of Hope Medical Center60
- Assistance Publique - Hôpitaux de Paris46
- St. Jude Children's Research Hospital43
- Peking University People's Hospital41
Where studies are running
- California406
- Texas186
- Maryland149
- Alabama146
- Arizona123
- Florida111
- Massachusetts101
- New York98
- Ohio71
- Minnesota68
Recruiting studies5,086 total
- NCT05757245RecruitingPhase 1
Safety and effectiveness of GMCN-508A for transfusion-dependent alpha thalassemia
This Phase 1 study tests a new medicine (GMCN-508A) to see how safe it is and whether it can help people with transfusion-dependent alpha thalassemia. Participants are also expected to follow a treatment plan that includes stem cell transplantation preparation.
Nanning, GuangxiAges 5–35 - NCT05868499Enrolling by invitationPhase 1
Study follow-up for people who finished the first trial
This Phase 1 study is a follow-up “rollover” for people who already completed the 12-month visit of an earlier study. It checks what happens next after that prior study and may help doctors understand the ongoing safety and effects of the treatment.
Cincinnati, OhioAges 18 years+ - NCT06034535RecruitingPhase 2
A stem cell transplant trial using special donor cells
This trial tests a new way to give donor cells after a stem cell transplant to help the body accept them. It may help patients who need a transplant but don't have a perfectly matched donor.
Hong KongAges Up to 18 years - NCT07309900RecruitingPhase 1
Testing IASO208 for relapsed or hard-to-treat B-cell cancers
This trial tests a new treatment called IASO208 for people with certain types of B-cell lymphoma that have come back or not responded to standard treatments. It aims to see if the drug can help shrink tumors and control the cancer.
Wuhan, HubeiAges 18–75 - NCT06996132RecruitingPhase 2
Combination treatment for aggressive B-cell lymphoma that has returned
This trial tests a new combination approach for people whose aggressive B-cell lymphoma has come back or not responded to treatment. It uses a bispecific antibody (a type of drug that helps immune cells attack cancer cells) followed by CAR-T cell therapy (reprogramming your own immune cells to find and kill cancer), sometimes with a stem cell transplant.
TianjinAges 18–65 - NCT07741279Recruiting
Enarodustat for anemia in chronic kidney disease patients
This study tests a daily pill that helps people with chronic kidney disease and anemia make more red blood cells, which may reduce the need for other anemia treatments. It is for patients who are not on dialysis and do not plan to start dialysis or have a kidney transplant within the next six months.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT06200116Recruiting
Testing a new tool for outlining healthy tissue in radiation plans
This study tests a new computer tool that helps doctors accurately outline healthy organs during radiation planning. It is for Mayo Clinic staff who already do this work.
Scottsdale, ArizonaAges Any age - NCT06977750Recruiting
Gelatin fluid for safe blood volume during surgery
This trial is testing a special fluid called succinylated gelatin (a type of colloid) given during surgery to help maintain blood volume. It is for people having planned surgery lasting less than 6 hours and who are in generally good health, without major heart, liver, or kidney problems.
Changsha, HunanAges 18–65 - NCT06874530Recruiting
Isatuximab for multiple myeloma with 1q21 abnormality
This trial tests if adding the drug isatuximab to standard treatments helps people whose multiple myeloma has returned or stopped responding, especially if their cancer cells have an extra copy of a certain gene (1q21). The study checks how well these drugs work together.
BolognaAges 18 years+ - NCT05943964Recruiting
Online exercise rehab after stem cell transplant
This trial tests a virtual (online) exercise program to help people recover strength and function after an allogeneic stem cell transplant. It may help you keep moving safely from home, if your doctor clears you for exercise and you can do the sessions with the needed support.
Atlanta, GeorgiaAges 8–23 - NCT05539079Recruiting
Long-term study of MGUS and how it may change over time
This study follows people with MGUS (a blood condition that usually does not cause symptoms right away) to learn how it progresses over the long term. If you have MGUS or might have it, your results may help doctors understand risk and changes over time.
Oxford, OxfordshireAges 18 years+ - NCT06966154RecruitingPhase 1/Phase 2
Tislelizumab with golidocitinib and selinexor for NK/T-cell lymphoma
This trial tests a combination of three drugs for people with NK/T-cell lymphoma that has come back or not responded to previous treatment. It aims to see if this new mix is safe and effective. You may qualify if your lymphoma returned after certain therapies or didn't respond to them.
Shanghai, ShangaiAges 18 years+ - NCT06963320RecruitingPhase 2
Preventing blood clots after knee replacement with H001
This trial tests whether an experimental capsule (H001) can prevent dangerous blood clots after knee replacement surgery. It is for people who are scheduled for a first-time total knee replacement and are willing to take the study drug instead of standard blood thinners.
Shanghai, Shanghai MunicipalityAges 18–74 - NCT06961630RecruitingEarly Phase 1
Heart protection after surgery
This trial tests if a personalized approach with blood thinners and statins can reduce heart risks after non-cardiac surgery. It is for adults 45 and older who had a heart injury during or after surgery.
New York, New YorkAges 45 years+ - NCT03206372Recruiting
Study of blood clot risk during hormone use in families
This study looks at what increases the risk of deep vein thrombosis or a lung blood clot (venous thromboembolism) in women who are using hormones. Researchers compare close family members to understand inherited risk and hormone-related triggers, which may help with prevention in the future.
BrestAges 16 years+ - NCT06745687Recruiting
BCMA/CD3 antibody for high-risk smoldering myeloma
This trial tests a new medicine called a BCMA/CD3 bispecific antibody for people with a very early form of multiple myeloma called high-risk smoldering myeloma. The goal is to see if this treatment can stop the disease from getting worse.
TianjinAges 18–78 - NCT06753838Recruiting
Choosing Blood Thinners for Clotting Tests Using PFA-200
This study looks at how well a blood test (PFA-200) works to check clotting in people who take different types of blood thinners. You don't need any extra procedures—just your regular blood draw.
DijonAges 18 years+ - NCT07225920Enrolling by invitation
Understanding needs of older patients before cancer treatment
This study interviews patients, caregivers, and clinicians to learn what older adults need before starting cancer treatments like chemotherapy or immunotherapy. The goal is to improve care and support for patients aged 65 and older.
Tuscaloosa, AlabamaAges 18 years+ - NCT06946407Recruiting
Chemotherapy combination for brain lymphoma
This trial tests a combination of chemotherapy drugs to treat lymphoma that started in your brain. The goal is to see if this treatment helps without having to use whole-brain radiation.
ChangchunAges Up to 60 years - NCT07302880Recruiting
How biotin affects blood test results
This study looks at how taking biotin (a common vitamin) might interfere with routine blood tests. It is for healthy individuals who want to understand if their vitamin supplement could change their lab results.
CopenhagenAges 20–70 - NCT06939803Recruiting
AI tool to prevent blood clots in hospitalized patients
This trial tests an AI tool that helps doctors prevent blood clots in hospitalized patients. If you are admitted to a participating Vanderbilt hospital, you may be part of this study.
Nashville, TennesseeAges Any age - NCT06937554Recruiting
Function and nutrition in fit leukemia patients
This trial looks at how exercise and nutrition affect fit adult leukemia patients during intensive chemotherapy. It aims to understand how to best support your recovery and well-being.
Rome, RMAges 18–70 - NCT03758989RecruitingPhase 2
PET-guided treatment and monitoring for limited-stage lymphoma
This Phase 2 study tests a treatment approach guided by PET scans, plus non-invasive monitoring, for adults with limited-stage diffuse large B-cell lymphoma (a type of lymphoma). It may help by tailoring therapy based on scan and other follow-up information, aiming for better outcomes with fewer invasive steps.
Rochester, New YorkAges 18 years+ - NCT06930443Recruiting
Oxygen use and organ injury after heart-lung bypass surgery
This trial looks at how oxygen is used during heart surgery that uses a heart-lung machine, and whether low oxygen levels can lead to organ damage. It may help doctors better understand how to protect patients during surgery.
Uppsala, SwedenAges 18 years+
Common questions
- How many blood & lymphatic clinical trials are recruiting?
- Clin2 is tracking 5,086 recruiting hematology studies from the U.S. registry right now, out of 7,699 we cover in this area in total.
- What does “Blood & lymphatic” cover here?
- Anemia, clotting disorders, and other conditions of the blood and lymphatic system. We group each study into blood & lymphatic based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a blood & lymphatic trial near me?
- Use the search to filter blood & lymphatic studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.